TIMP-1 Antibody (TIMP1/1944R) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08713JF549
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
Janelia Fluor 549
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # TIMP1/1944R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for TIMP-1 Antibody (TIMP1/1944R) [Janelia Fluor® 549]
Immunogen
Recombinant human full-length TIMP-1 protein (Uniprot: P01033)
Localization
Secreted. Cytoplasm.
Marker
Colorectal and Lymph Node Metastasis Marker
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for TIMP-1 Antibody (TIMP1/1944R) [Janelia Fluor® 549]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TIMP-1
Long Name
Tissue Inhibitors of Metalloproteinases 1
Alternate Names
TIMP1
Gene Symbol
TIMP1
Additional TIMP-1 Products
Product Documents for TIMP-1 Antibody (TIMP1/1944R) [Janelia Fluor® 549]
Product Specific Notices for TIMP-1 Antibody (TIMP1/1944R) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...